Alkermes
$24.06
24H
Market Cap
Volume
Supply
Price Chart
About Alkermes - ALKS
Alkermes plc is a biopharmaceutical company that focuses on developing innovative medicines designed to address unmet medical needs in the fields of central nervous system (CNS) disorders, such as schizophrenia, depression, and addiction. The company's portfolio includes both marketed products and compounds in various stages of clinical development.
What are Alkermes's core values and mission statement?
Alkermes plc is focused on developing innovative medicines to improve patient outcomes in neuroscience and oncology. Their mission emphasizes their commitment to addressing unmet medical needs and advancing science in a way that contributes to society.
Who founded Alkermes and when?
Alkermes plc was founded by Michael Wall in 1987.
Who leads Alkermes?
As of my last update, Richard Pops serves as the Chairman and Chief Executive Officer of Alkermes plc.
Where is Alkermes located, and what is its base country?
Alkermes plc is headquartered in Dublin, Ireland, which is its base country.
On which exchanges is Alkermes traded?
Alkermes plc is traded on the NASDAQ under the ticker symbol ALKS.
Historical data
Alkermes (ALKS) Price Live Data
The live price of Alkermes (ALKS) is $24.06, with a trading volume of 1,118,957 in the last 24 hours. Wrapstocks updates the ALKS price in real-time. Alkermes is up 0.86% in the last 24 hours. The company has a live market cap of $4,069,721,088.00 and a supply of 169,183,999 ALKS stocks.
Alkermes (ALKS) is traded on NASDAQ Stock Exchange, and currently, the market is closed; trading will be resumed in 3 hours and 16 minutes.
